Jazz Pharmaceuticals plc’s filing revealed that its SVP, Technical Operations Henderson Mary Elizabeth unloaded Company’s shares for reported $0.38 million on Dec 09 ’25. In the deal valued at $169.51 per share,2,238 shares were sold. As a result of this transaction, Henderson Mary Elizabeth now holds 19,508 shares worth roughly $3.31 million.
Then, MARY ELIZABETH HENDERSON bought 2,238 shares, generating $379,365 in total proceeds.
Before that, Carr Patricia sold 4,660 shares. Jazz Pharmaceuticals plc shares valued at $797,783 were divested by the SVP, Chief Accounting Officer at a price of $171.20 per share. As a result of the transaction, Carr Patricia now holds 7,012 shares, worth roughly $1.19 million.
UBS downgraded its Jazz Pharmaceuticals plc [JAZZ] rating to a Neutral from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Deutsche Bank’s analysts, who began to cover the stock in mid July with a ‘”a Buy”‘ rating. UBS also remained covering JAZZ and has increased its forecast on March 07, 2025 with a “Buy” recommendation from previously “Neutral” rating. Cantor Fitzgerald revised its rating on February 26, 2025. It rated JAZZ as “a Neutral” which previously was an “an Overweight”.
Price Performance Review of JAZZ
On Tuesday, Jazz Pharmaceuticals plc [NASDAQ:JAZZ] saw its stock jump 0.12% to $169.73. Over the last five days, the stock has gained 4.60%. Jazz Pharmaceuticals plc shares have risen nearly 37.32% since the year began. Nevertheless, the stocks have risen 37.82% over the past one year. While a 52-week high of $182.99 was reached on 11/18/25, a 52-week low of $95.49 was recorded on 04/09/25.
Levels Of Support And Resistance For JAZZ Stock
The 24-hour chart illustrates a support level at 168.09, which if violated will result in even more drops to 166.46. On the upside, there is a resistance level at 170.80. A further resistance level may holdings at 171.88.
How much short interest is there in Jazz Pharmaceuticals plc?
A steep rise in short interest was recorded in Jazz Pharmaceuticals plc stocks on 2025-11-28, dropping by -0.14 million shares to a total of 4.97 million shares. Yahoo Finance data shows the prior-month short interest on 2025-10-31 was 5.12 million shares. There was a decline of -2.85%, which implies that there is a negative sentiment for the stock.
